MedPath

EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)

Conditions
Non Small Cell Lung Cancer
Registration Number
NCT00982605
Lead Sponsor
Heidelberg University
Brief Summary

The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).

Detailed Description

NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age ≥ 18 years
  • Samples are collected before surgery or before any therapy
  • ECOG 0 or 1
  • Clinical stage I-II, T1-2, N0-1, M0)
  • Surgically respectable
  • Patient with enlarged med. lymphnodes (control group)
Exclusion Criteria
  • Previous RT/CHT
  • Previous or current cancer of other entity

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care

🇩🇪

Heidelberg, Germany

Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care
🇩🇪Heidelberg, Germany
Michael Kreuter, MD
Contact
49 / 6221 / 396
michael.kreuter@thoraxklinik-heidelberg.de

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.